Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer

Table 1

Clinical information of 522 TCGA-LUAD patients.

Variables	Statistics
Gender
Male (%)	242 (46.4%)
Female (%)	280 (53.6%)
Age
80~89 (%)	30 (5.8%)
70~79 (%)	150 (28.7%)
60~69 (%)	146 (28.0%)
50~59 (%)	83 (16.0%)
40~49 (%)	25 (4.8%)
30~39 (%)	2 (0.4%)
Not reported (%)	86 (16.3%)
Race
White (%)	393 (75.3%)
Black or African American (%)	53 (10.2%)
Asian (%)	8 (1.5%)
American Indian or Alaska native (%)	1 (0.2%)
Not reported (%)	67 (12.9%)
Status
Alive (%)	334 (64.0%)
Dead (%)	188 (36.0%)
Tumor stage
I (%)	279 (53.4%)
II (%)	124 (23.8%)
III (%)	85 (16.3%)
IV (%)	26 (5.0%)
Not reported (%)	8 (1.5%)

LUAD: lung adenocarcinoma.